Tranylcypromine Tablets bulk supplier for pharma manufacturers

Tranylcypromine Tablets 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg

Reference Brands: Parnate® (US & EU)

Tranylcypromine is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) that increases the levels of norepinephrine, serotonin, and dopamine in the brain by inhibiting their breakdown. This enhances mood and cognitive function. It is primarily used to treat major depressive disorder (MDD) in patients unresponsive to other antidepressants. Due to its MAOI activity, it requires strict dietary restrictions and careful drug interaction monitoring to avoid hypertensive crises.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Tranylcypromine, marketed under the well-known brand Parnate®, is a classic monoamine oxidase inhibitor (MAOI) used to treat major depressive disorder (MDD), especially in cases unresponsive to conventional antidepressants. Available as 10 mg oral tablets in both the US and EU, Tranylcypromine works by irreversibly inhibiting the MAO enzyme, increasing brain levels of serotonin, norepinephrine, and dopamine. Although dietary restrictions apply, it remains a vital option in psychiatric practice for severe and atypical depression. Connect with certified Tranylcypromine manufacturers and suppliers at Pharmatradz.com, your global B2B pharmaceutical marketplace.

Tranylcypromine Tablets — third party manufacturing & bulk supply

Tranylcypromine Tablets 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tranylcypromine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tranylcypromine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tranylcypromine Tablets →

Back to Listing

Frequently Asked Questions

Tranylcypromine Tablets is listed as Tablets in 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Tranylcypromine Tablets is referenced against Parnate® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.